AVITA Medical, Inc.
corporate_fare Company Profile
AVITA Medical, Inc. (NASDAQ:RCEL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for RCEL at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- AVITA Medical Reports Full-Year 2025 Results with Going Concern Warning, Details Debt Refinancing & Equity Raise
- AVITA Medical Reports Mixed Q4, Strong Full-Year 2025 Results, Guides for 12-19% Revenue Growth in 2026
- AVITA Medical Secures $60M Senior Secured Credit Facility, Refinances Debt, and Issues Warrants
- AVITA Medical Appoints Seasoned Healthcare Executive Joe Woody to Board of Directors
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$71.61M
Net Income
-$48.59M
Diluted EPS
-$1.74
Op. Cash Flow
-$31.2M
Free Cash Flow
-$32.2M
Gross Profit
$58.82M
Operating Income
-$42.53M
Cash & Equivalents
$10.24M
Total Debt
$42.98M
Debt / Equity
-2.58×
Net Margin
-67.8%
Shares Outstanding
30.57M sh
Source: 10-K · filed 2026-02-12 · accession 0001193125-26-049031
show_chartPrice Chart
Loading chart...
feed RCEL - Filings & News (Page 2)
RCEL
Feb 12, 2026, 5:20 PM EST
Price at Filing:
$3.54
Real-time Price:
$15.31
Change:
+$11.77 (+332%)
Market Cap:
$490.784M
RCEL
Feb 12, 2026, 4:15 PM EST
Price at Filing:
$3.50
Real-time Price:
$15.31
Change:
+$11.81 (+337%)
Market Cap:
$490.784M
RCEL
Jan 13, 2026, 8:30 AM EST
Price at Filing:
$3.60
Real-time Price:
$15.31
Change:
+$11.71 (+325%)
Market Cap:
$490.784M
RCEL
Jan 05, 2026, 4:11 PM EST
Price at Filing:
$3.47
Real-time Price:
$15.31
Change:
+$11.84 (+341%)
Market Cap:
$490.784M